These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 31380591
1. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels. Xie Y, Yi W, Zhang L, Lu Y, Hao HX, Gao YJ, Ran CP, Lu HH, Chen QQ, Shen G, Wu SL, Chang M, Ping-Hu L, Liu RY, Sun L, Wan G, Li MH. J Viral Hepat; 2019 Jul; 26 Suppl 1():42-49. PubMed ID: 31380591 [Abstract] [Full Text] [Related]
2. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels. Ormeci A, Aydın Y, Sumnu A, Baran B, Soyer OM, Pınarbasi B, Gokturk S, Gulluoglu M, Onel D, Badur S, Akyuz F, Karaca C, Demir K, Besisik F, Kaymakoglu S. Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844 [Abstract] [Full Text] [Related]
3. Risk factors for significant histological changes in both HBeAg positive and negative treatment-naive chronic hepatitis B with persistently normal alanine aminotransferase level. Xu C, Zhao Y, Chen H, Ren W, Yang X, Zheng W, Yin Q, Pan H. BMC Infect Dis; 2024 Oct 08; 24(1):1120. PubMed ID: 39379873 [Abstract] [Full Text] [Related]
4. Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads. Huang YH, Hung HH, Chan CC, Lai CR, Chu CJ, Huo TI, Lee PC, Su CW, Lan KH, Huang HC, Lee IC, Lin HC, Lee SD. Clin Vaccine Immunol; 2010 Jun 08; 17(6):1048-53. PubMed ID: 20427626 [Abstract] [Full Text] [Related]
7. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase. Zhou J, Song L, Zhao H, Yan L, Ma A, Xie S, Zhang X, Zhang D, Xie Q, Zhang G, Shang J, Cheng J, Zhao W, Zou Z, Zhang M, Xia N, Wang G. Sci Rep; 2017 Jun 05; 7(1):2747. PubMed ID: 28584279 [Abstract] [Full Text] [Related]
10. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis IS, Goulis J, Giannousis J, Bilalis A, Kafiri G, Tzourmakliotis D, Archimandritis AJ. Hepatology; 2008 Nov 05; 48(5):1451-9. PubMed ID: 18924246 [Abstract] [Full Text] [Related]
15. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA. Yao K, Wang J, Wang L, Xia J, Yan X, Wu W, Liu J, Wang L, Yin S, Tong X, Ding W, Huang R, Wu C. J Med Virol; 2022 Feb 05; 94(2):659-666. PubMed ID: 34499353 [Abstract] [Full Text] [Related]
16. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ. Hepatology; 2007 Oct 05; 46(4):1057-70. PubMed ID: 17654702 [Abstract] [Full Text] [Related]
17. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection. Diktas H, Karacaer Z, Özturk II, Cicek H. Postgrad Med J; 2016 Dec 05; 92(1094):693-696. PubMed ID: 27170311 [Abstract] [Full Text] [Related]
19. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase. Gao Y, Wang M, Liu X. Microbiol Spectr; 2024 Apr 02; 12(4):e0394123. PubMed ID: 38426768 [Abstract] [Full Text] [Related]